Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

By sjmartinez • April 18, 2023

Evering TH, Chew KW, Giganti MJ, Moser C, Pinilla M, Wohl DA, Currier JS, Eron JJ, Javan AC, Bender Ignacio R, Margolis D, Zhu Q, Ma J, Zhong L, Yan L, D'Andrea Nores U, Hoover K, Mocherla B, Choudhary MC, Deo R, Ritz J, Fischer WA, Fletcher CV, Li JZ, Hughes MD, Smith D, Daar ES; ACTIV-2/A5401 Study Team. Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19. Ann Intern Med. 2023 Apr 18. doi: 10.7326/M22-3428. Epub ahead of print. PMID: 37068272.

Tags: Infectious Diseases, Publications

Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083

Clement ME, Hanscom B, Haines D, Bazan JA, Chotirosniramit N, Kofron R, Mannheimer S, Mayer KH, Torres Silva MS, Soto-Torres L, Rinehart AR, Rooney JF,[...]

Early Outcomes of Mental Health Screening Integrated Into Routine HIV Care in Malawi

Chikuse E, Hagstrom C, Smith D, Banda T, Chimbaka H, Nkhoma Z, Samuko M, Lichenya J, Hoffman R, Njala J, Phiri S, Phiri K, van[...]

Health System Factors Influencing the Integration of Pre-Exposure Prophylaxis into Antenatal and Postnatal Clinic Services in Cape Town, South Africa

Court L, Nelson A, Taliep R, Dean SS, Mvududu R, Knight L, Dovel K, Coates T, Myer L, Davey DLJ. Health System Factors Influencing the[...]